| Inventor | Institute |
|---|---|
| Mike Horton | Queen Mary University of London |
| SKU: | 152690 |
|---|---|
| Product description: | Aminopeptidase N (CD13) is a cell-surface metalloprotease involved in the metabolism of regulatory peptides. 22A5 may be useful for the diagnosis and immunophenotyping of leukaemia. |
| Alternate name: | Alanyl Aminopeptidase; Membrane; Microsomal Aminopeptidase; Aminopeptidase M; Myeloid Plasma Membrane Glycoprotein CD13; GP15; CD13; PEPN |
| Conjugation: | Unconjugated |
| Isotype: | IgG2a kappa |
| Immunogen: | A cell suspension containing osteoclasts from osteoclastomas. |
| Cat. #: | 152690 |
|---|---|
| Provenance and Ownership: | The Anti-CD13 [22A5] mAb is owned by Cancer Research UK. CancerTools supplies the Anti-CD13 [22A5] mAb under licence from Cancer Research UK and is the authorised source for its distribution. Sourcing Anti-CD13 [22A5] mAb directly from the IP owner ensures authenticity, provenance and compliance with all applicable licensing and research use requirements. |
| Tool sub type: | Primary antibody |
| Unit size: | 100 ug |
| Research Fields: | Biochemistry; Cancer; Cell biology; Metabolism; Stem cell biology |
| Application: | FACS ; IHC ; IP |
| Target: | Aminopeptidase N (CD13) |
| Reactivity: | Human |
| Clone: | 22A5 |
| Host: | Mouse |
| Class: | Monoclonal |
| Primary citation: | Horton et al. 1985. Cancer Res. 45(11 Pt 2):5663-9. PMID: 4053038. |
| Target background: | Aminopeptidase N (CD13) is a cell-surface metalloprotease involved in the metabolism of regulatory peptides. 22A5 may be useful for the diagnosis and immunophenotyping of leukaemia. |
|---|
| Format: | Liquid |
|---|---|
| Concentration: | 1 mg/ml |
| Storage buffer: | PBS with 0.02% azide |
| Storage conditions: | -15° C to -25° C |
| Shipping conditions: | Dry ice |
| References: |
Murray et al. 1995. Leuk Lymphoma. 17(5-6):501-8. PMID: 7549844. Immunocytochemical studies of an antigen in a human T-cell lymphoma line (Jurkat) recognized by certain monoclonal antibodies to CD-13 (aminopeptidase-N). van Hal et al. 1994. J Immunol. 153(6):2718-28. PMID: 7915741. Potential indirect anti-inflammatory effects of IL-4. Stimulation of human monocytes, macrophages, and endothelial cells by IL-4 increases aminopeptidase-N activity (CD13 EC 3.4.11.2). Ashmun et al. 1990. Blood. 75(2):462-9. PMID: 1967220. Metalloprotease activity of CD13/aminopeptidase N on the surface of human myeloid cells. Look et al. 1989. J Clin Invest. 83(4):1299-307. PMID: 2564851. Human myeloid plasma membrane glycoprotein CD13 (gp150) is identical to aminopeptidase N. Horton et al. 1985. Cancer Res. 45(11 Pt 2):5663-9. PMID: 4053038. Monoclonal antibodies to osteoclastomas (giant cell bone tumors): definition of osteoclast-specific cellular antigens. |
|---|
Please note we may take up to three days to respond to your enquiry.
CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.